IDEAS home Printed from https://ideas.repec.org/a/eee/respol/v47y2018i7p1215-1228.html
   My bibliography  Save this article

Knowledge dissemination in clinical trials: Exploring influences of institutional support and type of innovation on selective reporting

Author

Listed:
  • Salandra, Rossella

Abstract

This paper contributes to the ongoing debate on the reliability of published research. In particular, this study focuses on the selective reporting of research findings in clinical trials, defined as the publication of only part of the findings originally recorded during a research study, on the basis of the results. Selective reporting can lead to concerns ranging from publishing flawed scientific knowledge, to skewing medical evidence, to wasting time and resources invested in the conduct of research. Drawing upon a unique hand-collected dataset, this study investigates the contextual factors associated with selective reporting. Using ‘risk of bias’ ratings assessed based on expert judgment and presented in systematic reviews of clinical literature, this study explores whether selective reporting is associated with: (1) the source of institutional support; and, (2) the type of innovation evaluated. The results indicate that the odds of selective reporting are higher for industry-funded studies than for publicly-funded studies; however, this effect is restricted to studies where at least one author is industry-affiliated. In addition, the results suggest that selective reporting is more likely in projects exploring radical innovation, compared to those investigating incremental innovation.

Suggested Citation

  • Salandra, Rossella, 2018. "Knowledge dissemination in clinical trials: Exploring influences of institutional support and type of innovation on selective reporting," Research Policy, Elsevier, vol. 47(7), pages 1215-1228.
    • Handle: RePEc:eee:respol:v:47:y:2018:i:7:p:1215-1228
    DOI: 10.1016/j.respol.2018.04.005
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0048733318300866
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.respol.2018.04.005?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. John P A Ioannidis, 2005. "Why Most Published Research Findings Are False," PLOS Medicine, Public Library of Science, vol. 2(8), pages 1-1, August.
    2. Jeff S. Armstrong & Michael R. Darby & Lynne G. Zucker, 2003. "Commercializing knowledge: university science, knowledge capture and firm performance in biotechnology," Proceedings, Federal Reserve Bank of Dallas, issue Sep, pages 149-170.
    3. Philippe Aghion & Mathias Dewatripont & Jeremy C. Stein, 2008. "Academic freedom, private‐sector focus, and the process of innovation," RAND Journal of Economics, RAND Corporation, vol. 39(3), pages 617-635, September.
    4. Carolina Riveros & Agnes Dechartres & Elodie Perrodeau & Romana Haneef & Isabelle Boutron & Philippe Ravaud, 2013. "Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals," PLOS Medicine, Public Library of Science, vol. 10(12), pages 1-12, December.
    5. Nicola Lacetera & Lorenzo Zirulia, 2011. "The Economics of Scientific Misconduct," The Journal of Law, Economics, and Organization, Oxford University Press, vol. 27(3), pages 568-603.
    6. Stephan, Paula E., 2010. "The Economics of Science," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 1, chapter 0, pages 217-273, Elsevier.
    7. Lim, Kwanghui, 2004. "The relationship between research and innovation in the semiconductor and pharmaceutical industries (1981-1997)," Research Policy, Elsevier, vol. 33(2), pages 287-321, March.
    8. Hicks, Diana, 1995. "Published Papers, Tacit Competencies and Corporate Management of the Public/Private Character of Knowledge," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 4(2), pages 401-424.
    9. repec:bla:jindec:v:46:y:1998:i:2:p:157-82 is not listed on IDEAS
    10. Azoulay, Pierre & Bonatti, Alessandro & Krieger, Joshua L., 2017. "The career effects of scandal: Evidence from scientific retractions," Research Policy, Elsevier, vol. 46(9), pages 1552-1569.
    11. Necker, Sarah, 2014. "Scientific misbehavior in economics," Research Policy, Elsevier, vol. 43(10), pages 1747-1759.
    12. Kerry Dwan & Douglas G Altman & Juan A Arnaiz & Jill Bloom & An-Wen Chan & Eugenia Cronin & Evelyne Decullier & Philippa J Easterbrook & Erik Von Elm & Carrol Gamble & Davina Ghersi & John P A Ioannid, 2008. "Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias," PLOS ONE, Public Library of Science, vol. 3(8), pages 1-31, August.
    13. Peter C Gøtzsche & Asbjørn Hróbjartsson & Helle Krogh Johansen & Mette T Haahr & Douglas G Altman & An-Wen Chan, 2007. "Ghost Authorship in Industry-Initiated Randomised Trials," PLOS Medicine, Public Library of Science, vol. 4(1), pages 1-6, January.
    14. Partha, Dasgupta & David, Paul A., 1994. "Toward a new economics of science," Research Policy, Elsevier, vol. 23(5), pages 487-521, September.
    15. Daniele Fanelli & Rodrigo Costas & Vincent Larivière, 2015. "Misconduct Policies, Academic Culture and Career Stage, Not Gender or Pressures to Publish, Affect Scientific Integrity," PLOS ONE, Public Library of Science, vol. 10(6), pages 1-18, June.
    16. Pierre Azoulay, 2002. "Do Pharmaceutical Sales Respond to Scientific Evidence?," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 11(4), pages 551-594, December.
    17. Ashish Arora & Michelle Gittelman & Sarah Kaplan & John Lynch & Will Mitchell & Nicolaj Siggelkow & Brent Goldfarb & Andrew A. King, 2016. "Scientific apophenia in strategic management research: Significance tests & mistaken inference," Strategic Management Journal, Wiley Blackwell, vol. 37(1), pages 167-176, January.
    18. Francisco Polidoro & Matt Theeke, 2012. "Getting Competition Down to a Science: The Effects of Technological Competition on Firms' Scientific Publications," Organization Science, INFORMS, vol. 23(4), pages 1135-1153, August.
    19. David B. Allison & Andrew W. Brown & Brandon J. George & Kathryn A. Kaiser, 2016. "Reproducibility: A tragedy of errors," Nature, Nature, vol. 530(7588), pages 27-29, February.
    20. Iain M. Cockburn & Rebecca M. Henderson, 1998. "Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery," Journal of Industrial Economics, Wiley Blackwell, vol. 46(2), pages 157-182, June.
    21. Raymond Fisman & Edward Miguel, 2007. "Corruption, Norms, and Legal Enforcement: Evidence from Diplomatic Parking Tickets," Journal of Political Economy, University of Chicago Press, vol. 115(6), pages 1020-1048, December.
    22. J. L. Hutton & Paula R. Williamson, 2000. "Bias in meta‐analysis due to outcome variable selection within studies," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 49(3), pages 359-370.
    23. Mookerjee, Rajen, 2006. "A meta-analysis of the export growth hypothesis," Economics Letters, Elsevier, vol. 91(3), pages 395-401, June.
    24. Koenig, Michael E. D., 1983. "A bibliometric analysis of pharmaceutical research," Research Policy, Elsevier, vol. 12(1), pages 15-36, February.
    25. Daniele Fanelli, 2010. "Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States Data," PLOS ONE, Public Library of Science, vol. 5(4), pages 1-7, April.
    26. Leonard P Freedman & Iain M Cockburn & Timothy S Simcoe, 2015. "The Economics of Reproducibility in Preclinical Research," PLOS Biology, Public Library of Science, vol. 13(6), pages 1-9, June.
    27. Daniele Fanelli, 2009. "How Many Scientists Fabricate and Falsify Research? A Systematic Review and Meta-Analysis of Survey Data," PLOS ONE, Public Library of Science, vol. 4(5), pages 1-11, May.
    28. Jared Harris & Philip Bromiley, 2007. "Incentives to Cheat: The Influence of Executive Compensation and Firm Performance on Financial Misrepresentation," Organization Science, INFORMS, vol. 18(3), pages 350-367, June.
    29. Sternitzke, Christian, 2010. "Knowledge sources, patent protection, and commercialization of pharmaceutical innovations," Research Policy, Elsevier, vol. 39(6), pages 810-821, July.
    30. Furman, Jeffrey L. & Jensen, Kyle & Murray, Fiona, 2012. "Governing knowledge in the scientific community: Exploring the role of retractions in biomedicine," Research Policy, Elsevier, vol. 41(2), pages 276-290.
    31. Michelle Gittelman & Bruce Kogut, 2003. "Does Good Science Lead to Valuable Knowledge? Biotechnology Firms and the Evolutionary Logic of Citation Patterns," Management Science, INFORMS, vol. 49(4), pages 366-382, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Walsh, John P. & Lee, You-Na & Tang, Li, 2019. "Pathogenic organization in science: Division of labor and retractions," Research Policy, Elsevier, vol. 48(2), pages 444-461.
    2. Hameeda A. AlMalki & Christopher M. Durugbo, 2023. "Systematic review of institutional innovation literature: towards a multi-level management model," Management Review Quarterly, Springer, vol. 73(2), pages 731-785, June.
    3. Leonardo Pompa, 2021. "Exponential Atlases: A Metaphysical Approach to the Organizational Rapid Growth," International Journal of Business and Management, Canadian Center of Science and Education, vol. 14(4), pages 143-143, July.
    4. Blandinieres, Florence & Pellens, Maikel, 2021. "Scientist's industry engagement and the research agenda: Evidence from Germany," ZEW Discussion Papers 21-001, ZEW - Leibniz Centre for European Economic Research.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Rotolo, Daniele & Camerani, Roberto & Grassano, Nicola & Martin, Ben R., 2022. "Why do firms publish? A systematic literature review and a conceptual framework," Research Policy, Elsevier, vol. 51(10).
    2. Simeth, Markus & Lhuillery, Stephane, 2015. "How do firms develop capabilities for scientific disclosure?," Research Policy, Elsevier, vol. 44(7), pages 1283-1295.
    3. Roberto Camerani & Daniele Rotolo & Nicola Grassano, 2018. "Do Firms Publish? A Multi-Sectoral Analysis," SPRU Working Paper Series 2018-21, SPRU - Science Policy Research Unit, University of Sussex Business School.
    4. Simeth, Markus & Raffo, Julio D., 2013. "What makes companies pursue an Open Science strategy?," Research Policy, Elsevier, vol. 42(9), pages 1531-1543.
    5. Salandra, Rossella & Criscuolo, Paola & Salter, Ammon, 2021. "Directing scientists away from potentially biased publications: the role of systematic reviews in health care," Research Policy, Elsevier, vol. 50(1).
    6. Jong, Simcha & Slavova, Kremena, 2014. "When publications lead to products: The open science conundrum in new product development," Research Policy, Elsevier, vol. 43(4), pages 645-654.
    7. Michaël Bikard, 2018. "Made in Academia: The Effect of Institutional Origin on Inventors’ Attention to Science," Organization Science, INFORMS, vol. 29(5), pages 818-836, October.
    8. Henry Sauermann & Michael Roach, 2011. "Not All Scientists pay to be Scientists:," DRUID Working Papers 11-03, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
    9. Subramanian, Annapoornima M. & Lim, Kwanghui & Soh, Pek-Hooi, 2013. "When birds of a feather don’t flock together: Different scientists and the roles they play in biotech R&D alliances," Research Policy, Elsevier, vol. 42(3), pages 595-612.
    10. Kiri, Bralind & Lacetera, Nicola & Zirulia, Lorenzo, 2018. "Above a swamp: A theory of high-quality scientific production," Research Policy, Elsevier, vol. 47(5), pages 827-839.
    11. Mueller-Langer, Frank & Fecher, Benedikt & Harhoff, Dietmar & Wagner, Gert G., 2019. "Replication studies in economics—How many and which papers are chosen for replication, and why?," Research Policy, Elsevier, vol. 48(1), pages 62-83.
    12. Sauermann, Henry & Roach, Michael, 2014. "Not all scientists pay to be scientists: PhDs’ preferences for publishing in industrial employment," Research Policy, Elsevier, vol. 43(1), pages 32-47.
    13. Maureen McKelvey & Bastian Rake, 2020. "Exploring scientific publications by firms: what are the roles of academic and corporate partners for publications in high reputation or high impact journals?," Scientometrics, Springer;Akadémiai Kiadó, vol. 122(3), pages 1323-1360, March.
    14. Soh, Pek-Hooi & Subramanian, Annapoornima M., 2014. "When do firms benefit from university–industry R&D collaborations? The implications of firm R&D focus on scientific research and technological recombination," Journal of Business Venturing, Elsevier, vol. 29(6), pages 807-821.
    15. Denisa Mindruta, 2013. "Value creation in university-firm research collaborations: A matching approach," Strategic Management Journal, Wiley Blackwell, vol. 34(6), pages 644-665, June.
    16. Martínez, Catalina & Parlane, Sarah, 2023. "Academic scientists in corporate R&D: A theoretical model," Research Policy, Elsevier, vol. 52(5).
    17. repec:wip:wpaper:6 is not listed on IDEAS
    18. Henry Sauermann & Paula Stephan, 2013. "Conflicting Logics? A Multidimensional View of Industrial and Academic Science," Organization Science, INFORMS, vol. 24(3), pages 889-909, June.
    19. Blind, Knut & Krieger, Bastian & Pellens, Maikel, 2022. "The interplay between product innovation, publishing, patenting and developing standards," Research Policy, Elsevier, vol. 51(7).
    20. Markus Simeth & Michele Cincera, 2016. "Corporate Science, Innovation, and Firm Value," Management Science, INFORMS, vol. 62(7), pages 1970-1981, July.
    21. Breschi, Stefano & Catalini, Christian, 2010. "Tracing the links between science and technology: An exploratory analysis of scientists' and inventors' networks," Research Policy, Elsevier, vol. 39(1), pages 14-26, February.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:respol:v:47:y:2018:i:7:p:1215-1228. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/respol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.